ALPK3变异致心肌病机制:核膜与肌节M带的必需假激酶
ALPK3功能未知,其功能缺失变异可致儿童和成人心肌病。研究利用同基因人诱导多能干细胞来源心肌细胞、小鼠和患者组织,发现ALPK3无催化活性,为假激酶,定位于核膜和肌节M带,与myomesin蛋白共定位;ALPK3缺失导致myomesin错误定位并失调M带蛋白,损害心肌细胞结构与功能。结论:ALPK3心肌病通过myomesin介导的力缓冲不足引起心室扩张,通过肌节蛋白稳态受损引起肥厚。
要点
- ALPK3是定位于核膜和肌节M带的假激酶,无催化活性。
- ALPK3功能缺失变异导致myomesin错误定位和M带蛋白失调。
- ALPK3心肌病心室扩张源于力缓冲不足,肥厚源于肌节蛋白稳态受损。
核心结论
- ALPK3是插入核膜和肌节M带的必需心脏假激酶,其缺失导致myomesin错误定位和M带蛋白失调,进而损害心肌细胞结构与功能。
研究设计与样本
- 研究使用同基因人诱导多能干细胞来源心肌细胞、小鼠和人类患者组织探索ALPK3的推定激酶活性及损伤性变异的后果。
主要发现
- 多个序列比对显示ALPK3的α激酶结构域有4个仅见于ALPK3的保守残基,提示进化分歧。
- 磷酸化蛋白质组学评估激酶结构域抑制和过表达均未检测到催化活性显著变化,确立ALPK3为假激酶。
- ALPK3与myomesin蛋白(MYOM1、MYOM2)在核膜和肌节M带共定位。
- ALPK3功能缺失变异导致myomesin蛋白错误定位,并失调多个参与肌节蛋白周转的M带蛋白,最终损害心肌细胞结构和功能。
临床怎么用
- ALPK3变异相关心肌病需关注myomesin介导的力缓冲不足和肌节蛋白稳态受损机制,可能为未来靶向干预提供方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: ALPK3 encodes α-kinase 3, a muscle-specific protein of unknown function. ALPK3 loss-of-function variants cause cardiomyopathy with distinctive clinical manifestations in both children and adults, but the molecular functions of ALPK3 remain poorly understood. METHODS: We explored the putative kinase activity of ALPK3 and the consequences of damaging variants using isogenic human induced pluripotent stem cell-derived cardiomyocytes, mice, and human patient tissues. RESULTS: Multiple sequence alignment of all human α-kinase domains and their orthologs revealed 4 conserved residues that were variant only in ALPK3, demonstrating evolutionary divergence of the ALPK3 α-kinase domain sequence. Phosphoproteomic evaluation of both ALPK3 kinase domain inhibition and overexpression failed to detect significant changes in catalytic activity, establishing ALPK3 as a pseudokinase. Investigations into alternative functions revealed that ALPK3 colocalized with myomesin proteins (MYOM1, MYOM2) at both the nuclear envelope and the sarcomere M-band. ALPK3 loss-of-function variants caused myomesin proteins to mislocalize and also dysregulated several additional M-band proteins involved in sarcomere protein turnover, which ultimately impaired cardiomyocyte structure and function. CONCLUSIONS: ALPK3 is an essential cardiac pseudokinase that inserts in the nuclear envelope and the sarcomere M-band. Loss of ALPK3 causes mislocalization of myomesins, critical force-buffering proteins in cardiomyocytes, and also dysregulates M-band proteins necessary for sarcomere protein turnover. We conclude that ALPK3 cardiomyopathy induces ventricular dilatation caused by insufficient myomesin-mediated force buffering and hypertrophy by impairment of sarcomere proteostasis.
引用
- Agarwal R, Wakimoto H, Paulo JA, et al. Pathogenesis of Cardiomyopathy Caused by Variants in ALPK3, an Essential Pseudokinase in the Cardiomyocyte Nucleus and Sarcomere. Circulation. 2022. PMID: 36321451. doi:10.1161/CIRCULATIONAHA.122.059688
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。